1. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017;Dai;Eur. Heart J. Qual. Care Clin. Outcomes,2021
2. Atrial fibrillation: JACC council perspectives;Chung;J. Am. Coll. Cardiol.,2020
3. Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation;Dorian;J. Cardiovasc. Pharmacol. Ther.,2010
4. Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug;Klieber;Pharmacol. Res. Perspect.,2014
5. Dronedarone;Tamargo;Drugs Today (Barc.),2011